Novavax’s protein-based vaccine approval fails to boost stock as demand in U.S. for shots and boosters remains low
admin U.S. health regulators authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new option…
Read MoreNVAX
Novavax’s protein-based vaccine approval fails to boost stock as demand for shots and boosters remains low
U.S. health regulators authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new option…
Read MoreFDA approves Novavax’s COVID-19 vaccine for those 18 and older
U.S. health regulators have authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new…
Read MoreNew omicron variant worries experts as it spreads in India, and Moderna says new booster offers better protection against BA.4 and BA.5
A new, highly infectious subvariant of omicron is raising concerns among scientists and health experts…
Read MoreNew omicron variant worries experts as it spreads in India, and Moderna says new booster offers better protection against BA.4 and BA.5
A new, highly infectious subvariant of omicron is raising concerns among scientists and health experts…
Read MoreCOVID hospitalizations dip for first time since mid-April, but daily deaths reach 2 1/2-month high
While the daily average of new COVID-19 cases have settled back into a low-100K range…
Read MoreThe U.S. bets billions of dollars on better COVID-19 boosters as it prepares for a spike in COVID-19 cases in the coming months
The U.S. is gearing up for another wave of COVID-19 infections in the fall and…
Read MoreThe U.S. bets billions of dollars on better COVID-19 boosters as it prepares for a spike in COVID-19 cases in the coming months
The U.S. is gearing up for another wave of COVID-19 infections in the fall and…
Read MoreNovavax is part of the FDA’s COVID-19 booster debate, but its vaccine still hasn’t been authorized
Novavax’s NVAX, +1.04% COVID-19 vaccine candidate played a front-and-center role during this week’s debate about…
Read MoreFDA advisers say the U.S. needs updated COVID-19 boosters to fight omicron
The U.S. should pursue a COVID-19 booster strategy that focuses on developing new shots that…
Read More